1 May 2009 in Expert Review of Endocrinology & Metabolism
It has recently been revealed that ghrelin, a hormone discovered in the stomach, has a potential therapeutic role in the treatment of diseased hearts. In human patients with heart failure and in animal models, repeated subcutaneous administration of ghrelin improves cardiac dysfunction and remodeling. Moreover, ghrelin treatment early after myocardial infarction effectively reduces fatal arrhythmia and, consequently, mortality. The beneficial effects of ghrelin result from a growth hormone increase, an orexigenic effect, direct actions to the cardiovascular cells and its potent inhibitory action on sympathetic nervous activity, which is excessively activated in cardiac diseases. These results suggest that ghrelin could be a promising novel therapeutic agent for cardiac diseases.
1 October 2011 in Hepatogastroenterology
The aim of this study was to clarify the relationship between plasma or mucosal ghrelin levels and endoscopic or histological severity, acid secretion and H. pylori infection associated with chronic gastritis. We measured plasma and mucosal ghrelin levels in 80 consecutive individuals with chronic gastritis, including 51 H. pylori-positive and 29 H. pylori-negative subjects. The topographic distribution of gastritis was divided into open type and closed type. During endoscopy, five adjacent biopsy specimens were obtained from the antrum, corpus and angulus. Using the updated Sydney System, histological parameters including activity, chronic inflammation, glandular atrophy and intestinal metaplasia were graded. Mucosal ghrelin, fasting plasma ghrelin, serum pepsinogen I and II, gastrin and H. pylori infection were all measured. All four measured histological parameters were significantly higher in H. pylori-positive patients than in H. pylori-negative patients. Serum pepsinogen I and II levels were also significantly higher in the H. pylori-positive group. Plasma and mucosal ghrelin levels correlated well with the topographic distribution of gastritis, and also with histological parameters of glandular atrophy in the corpus and angulus of the stomach. Plasma and mucosal ghrelin levels may reflect the extent of atrophy in the stomach irrespective of the presence of H. pylori infection, which is closely associated with the development of chronic gastritis.
31 December 2010 in Neuroscience Research